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The hereditary spastic paraplegias (HSPs) are a hetero­
geneous  group  of  neurodegenerative  disorders  that  all 
share  progressive  lower  limb  spastic  paralysis.  Despite 
their genetic and phenotypic heterogeneity (more than 
20  gene  loci  have  been  described),  all  HSPs  involve 
progressive degeneration of axonal tracts of corticospinal 
motor  neurons.  These  exceptionally  long  axons,  which 
can reach over a meter in length on their way from the 
motor cortex in the brain to the spinal cord, represent an 
extreme example of the challenges faced by a neuron to 
translate genetic information into cellular function over 
long distances. Perhaps not surprisingly, genes mutated 
in different manifestations of HSP affect diverse cellular 
functions such as cell adhesion, mitochondrial function/
energy metabolism and membrane trafficking [1].
The gene for the protein spartin was identified in the 
search for mutations causing a complicated form of HSP 
called  Troyer  syndrome.  A  single  base  deletion  was 
identified in the spartin gene, causing a frameshift muta­
tion and premature termination of the spartin protein [2]. 
The  amino  terminus  of  spartin  encodes  a  microtubule 
inter  acting  and  trafficking  (MIT)  domain  that  is  also 
found in trafficking proteins involved in protein degrada­
tion  through  the  endosomal/lysosomal  system.  Indeed, 
spartin  partly  localizes  to  endosomal  structures  and 
appears to facilitate degradation of activated epidermal 
growth factor receptors, a process that is attenuated in 
spartin­depleted cells [3,4].
Recent work [4,5], including a study by Hooper et al. 
[6]  published  in  BMC  Biology,  has  now  discovered  an 
unexpected  new  function  for  spartin.  All  three  groups 
describe  recruitment  of  spartin  to  newly  formed  lipid 
droplets  induced  by  oleic  acid  treatment  [4­6].  Lipid 
droplets  are  dynamic  lipid­storage  organelles  that  are 
formed  when  there  is  a  constant  exogenous  supply  of 
fatty  acids.  Upon  a  change  in  metabolic  conditions, 
stored neutral fats can be mobilized for lipolysis and can 
thereby contribute to the energy homeostasis of the cell 
[7].  Interestingly,  spartin’s  localization  to  lipid  droplets 
depends on the carboxy­terminal part of the protein that 
is deleted in Troyer syndrome [4,6], which suggests that 
defects  in  lipid­droplet  formation  and  dynamics  in 
neurons could underlie this syndrome.
What might be the role of spartin, a protein with no 
known  catalytic  activities,  in  lipid­droplet  dynamics? 
Spartin  is  mono­ubiquitinated  and  possesses  a  proline 
(P)­rich PY­motif (PPxY; Y is tyrosine and x is any amino 
acid), often found in proteins that interact with ubiquitin 
ligases of the Nedd4 family. Indeed, spartin was shown to 
interact  with  the  Nedd4­family  E3  ligases  AIP2,  AIP4 
(Itch) and AIP5 [5]. Hallmarks of these ubiquitin ligases 
are  an  amino­terminal  C2  domain  involved  in  lipid­
protein interaction, two to four WW domains responsible 
for substrate recognition via the PY motif, and a carboxy­
terminal catalytic HECT domain. Through their ubiquitin 
ligase activity, members of the Nedd4 family are involved 
in many biological processes, via proteasome­dependent 
degradation of cytosolic targets, regulation of endo  cyto  sis 
and  lysosomal  degradation  of  surface  receptors  and 
channels, or by aiding egress of viral particles through the 
endosomal  sorting  complexes  required  for  transport 
(ESCRT).
Hooper at al. [6] set out to analyze the significance of 
the interaction of spartin and the ubiquitin ligase AIP4. 
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spartin was not a substrate for AIP4­mediated ubiquitina­
tion. These observations are in agreement with those of 
Edwards et al. [4], who were unable to detect changes in 
spartin  ubiquitination  levels  upon  overexpression  or 
knockdown of AIP4 or AIP5. Yet, both these ubiquitin 
ligases  interact  with  spartin.  Instead,  spartin  seems  to 
play  a  role  in  the  localization  of  AIP4.  Whereas  over­
expressed  AIP4  shows  a  diffuse  cytosolic  distribution, 
coexpression of wild­type spartin promotes recruitment 
of AIP4 to lipid droplets; mutations of the PY motif in 
spartin that disrupt binding to AIP4 also disrupt spartin’s 
ability  to  recruit  AIP4,  without  affecting  spartin’s  own 
localization  to  the  droplets  [6].  These  findings  suggest 
that  spartin  binds  to  AIP4  through  its  PY  motif  to 
mediate spatial regulation of ubiquitination (Figure 1).
Hooper et al. [6] therefore investigated the involvement 
of spartin in the ubiquitination of known ubiquitin ligase 
substrates on the lipid­droplet membrane. One of these 
is adipophilin, and it and the proteins peripilin and TIP47 
form  the  PAT  family  of  peripherally  associated  mem­
brane  proteins  highly  enriched  on  lipid  droplets. 
Adipophilin plays a role in lipid droplet turnover, where 
it associates with lipid droplets at early stages of droplet 
biogenesis, but undergoes ubiquitin­induced degradation 
during mobilization of stored lipids. Thus, ubiquitination 
of lipid­­droplet­associated proteins has great regulatory 
potential [7]. Indeed, on knockdown of spartin, Hooper 
et al. [6] found that the ubiquitination of adipophilin is 
greatly  reduced,  supporting  a  role  for  spartin  in  the 
recruitment  of  ubiquitin  ligases  to  these  lipid  bodies 
(Figure 1). Together with the earlier reports, their find­
ings support a role for ubiquitination in the dynamics of 
lipid droplets, as depletion of endogenous spartin leads 
to apparent accumulation of lipid bodies in cells [4,6].
Spartin is therefore an addition to the list of mamma­
lian  adaptor  proteins  interacting  with  and  regulating 
Nedd4­family ligases. Other membrane­expressed adap­
tors for AIP4 and AIP2 containing PY motifs have been 
described recently. For example, Ndfip1 binds to AIP2 
through two PY motifs and mediates ubiquitination of 
the  membrane­bound  iron  transporter  DMT1  [8]. 
Similarly, AIP4 binds to its target JunB in T lymphocytes 
through  the  same  adaptor  protein,  Ndfip1,  to  allow 
ubiquitination of JunB and containment of JunB­depen­
dent signaling. AIP4­knockout mice and Ndfip1­knockout 
mice  both  develop  severe  autoimmunity  [9],  making  a 
strong  case  for  the  importance  of  adaptors  in  enabling 
substrate­ligase interaction, at least in some scenarios.
In addition, spartin binding to AIP4 seems to have a 
direct  effect  on  the  catalytic  activity  of  the  ubiquitin 
ligase. Intramolecular inhibition has been described for 
AIP4.  The  carboxy­terminal  HECT  domain  folds  back 
onto the WW domain by binding to a proline­rich region 
amino­terminal to the WW domains, greatly inhibiting 
AIP4’s  catalytic  activity.  Phosphorylation  events  in  the 
proline­rich  region  disrupt  the  intramolecular  inter­
actions and greatly stimulate the catalytic activity of AIP4 
[10].  A  similar  autoinhibitory  mechanism  has  been 
suggested  to  restrict  the  catalytic  activity  of  Nedd4­2, 
which  could  be  relieved  by  Nedd4­2  binding  to  a  PY 
motif­containing  bona  fide  substrate  (ENaC  [11]),  and 
Smurf2, in which the C2 domains bind to and inhibit the 
HECT domain [12]. Via its PY motif, spartin binds to the 
WW domains of AIP4 with high affinity, which Hooper 
et  al.  [6]  now  show  can  disrupt  the  intramolecular 
Figure 1. Spartin associates with lipid droplets and possesses a PY motif that recruits the ubiquitin ligase AIP4 (or other Nedd4-family 
ubiquitin ligases) via the AIP4 WW domains. Via its catalytic HECT domain, AIP4 promotes the ubiquitination of lipid-droplet-associated proteins, 
such as adipophilin, leading to regulation of turnover of the lipid droplets. Thus, spartin functions as an adaptor protein to promote ubiquitination 
(Ub) of lipid-droplet-associated proteins. In the absence of spartin, the catalytic activity of AIP4 is inhibited by intramolecular interactions (not shown).
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increase AIP4’s catalytic activity.
Thus, a scenario is emerging in which spartin recruits 
and activates Nedd4­family ligases for ubiquitination and 
degradation of lipid droplet proteins such as adipophilin. 
In response to extracellular changes, cells are well known 
to  utilize  the  ubiquitin/proteasome  system  to  control 
levels  of  transcription  factors,  cell­cycle  proteins  or 
mem  brane  receptors.  The  novel  findings  on  spartin 
suggest  a  role  for  ubiquitination  in  the  turnover  of  an 
organelle ­ the lipid droplet.
Given the original description of mutated spartin as the 
cause  of  a  particularly  devastating  form  of  HSP,  an 
important question to be investigated is the relevance of 
spartin’s association with lipid bodies to the development 
of HSP. As Hooper et al. discuss, another gene product, 
SPG17 or seipin, involved in a different variant of HSP, is 
implicated in lipid­droplet maintenance in yeast. Analysis 
of the specific role of spartin in neurons should yield a 
better  understanding  of  the  unexpected  connection 
between lipid­droplet dynamics and neuronal degeneration 
as seen in Troyer syndrome.
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